Sign Up to like & get
recommendations!
0
Published in 2020 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000001114
Abstract: To the Editor: Cardiogenic shock carries a high mortality rate. Over last decade increasing number of patients in cardiogenic shock are managed on the percutaneous ventricular assist device, Impella. This is usually a short-term device…
read more here.
Keywords:
impella;
purge solution;
solution;
argatroban purge ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Pharmacy Practice"
DOI: 10.1177/0897190018822105
Abstract: Background Impella CP® is a percutaneous left ventricular assist device that requires a heparin–dextrose purge solution. The manufacturer recommends heparin 50 units/mL, but supratherapeutic anticoagulation has been observed with this concentration. Objective The purpose of…
read more here.
Keywords:
anticoagulation;
heparin;
low dose;
purge solution ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Annals of Pharmacotherapy"
DOI: 10.1177/1060028020944831
Abstract: Background: The Impella is a percutaneous ventricular assist device (pVAD) that provides temporary hemodynamic support to patients with cardiogenic shock or for protected percutaneous coronary intervention. The manufacturer recommends a 50-U/mL concentration of heparin purge…
read more here.
Keywords:
heparin;
support;
heparin purge;
purge solution ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Annals of Pharmacotherapy"
DOI: 10.1177/10600280221124156
Abstract: Background: The Impella device is a continuous axial flow pump which provides hemodynamic support by expelling blood into the aorta. The manufacturer recommends using dextrose-based heparin containing solutions as the default purge. As an alternative…
read more here.
Keywords:
purge solution;
impella;
bicarbonate based;
based purge ... See more keywords